You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CCR7

Showing 1 - 25 of 1,372
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte

Active, not recruiting
  • AIDS-related Non-Hodgkin Lymphoma
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the

Active, not recruiting
  • AIDS-Related Burkitt Lymphoma
  • +5 more
  • Bethesda, Maryland
    NCI Lymphoid Malignancies Branch
Jul 31, 2022

Hand Eczema Trial in Worldwide (Ruxolitinib cream, Vehicle)

Withdrawn
  • Hand Eczema
  • Phoenix, Arizona
  • +48 more
Nov 14, 2022

Episodic Migraine Trial in Worldwide (Atogepant 60 mg, Placebo)

Completed
  • Episodic Migraine
  • Atogepant 60 mg
  • Placebo
  • Colton, California
  • +113 more
Aug 12, 2022

Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and

Not yet recruiting
  • Multiple Sclerosis
  • Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic plasmacytoid Dendritic Cells
  • (no location specified)
Oct 10, 2022

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Terminated
Has Results
  • Rheumatoid Arthritis (RA)
  • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
  • +29 more
Aug 18, 2021

Memory CD8+ T Cells With Sepsis Severity and

Recruiting
  • Sepsis
  • Inflammatory Response
    • Wuhan, Hubei, China
      Department of Critical Care Medicine, Union Hospital, Tongji Med
    May 16, 2023

    Transplant Failure Trial in Marseille (BLOOD SAMPLE ANALYSIS)

    Recruiting
    • Transplant Failure
    • BLOOD SAMPLE ANALYSIS
    • Marseille, Paca, France
      Assistance Publique Des Hopitaux de Marseille
    Oct 28, 2021

    Vitamin d Deficiency Trial in Nîmes (Vitamin D, Placebo)

    Not yet recruiting
    • Vitamin d Deficiency
    • Vitamin D
    • Placebo
    • Nîmes, France
      CHU de Nîmes
    Dec 8, 2022

    Vitiligo Trial in Cairo (oral mini pulse, Topical cream, targeted phototherapy)

    Not yet recruiting
    • Vitiligo
    • oral mini pulse
    • +2 more
    • Cairo, Egypt
      Cairo university hospitals, dermatology outpatient clinic
    Jan 31, 2023

    Lymphoma Trial in Canada (bortezomib, gemcitabine HCl)

    Completed
    • Lymphoma
    • Edmonton, Alberta, Canada
    • +10 more
    Apr 6, 2020

    COVID-19 Trial (RQ3013, Comirnaty)

    Not yet recruiting
    • COVID-19
    • RQ3013
    • Comirnaty
    • (no location specified)
    Nov 15, 2022

    Immune Aging, Aging Trial in Frankfurt (Softgel containing , Softgel containing 250mg of Urolithin A (Mitopure))

    Recruiting
    • Immune Aging
    • Aging
    • Softgel containing placebo
    • Softgel containing 250mg of Urolithin A (Mitopure)
    • Frankfurt, Germany
      Universitätsklinikum Frankfurt, Medizinische Klinik I, Gastroent
    Feb 9, 2023

    HIV I Infection Trial in United States (VIR-1111, Placebo)

    Active, not recruiting
    • HIV I Infection
    • VIR-1111
    • Placebo
    • Miami, Florida
    • +3 more
    Jul 22, 2022

    COVID-19 Trial (RQ3013, Comirnaty)

    Not yet recruiting
    • COVID-19
    • RQ3013
    • Comirnaty
    • (no location specified)
    May 26, 2022

    Cutaneous T-Cell Lymphoma Trial in Worldwide (KW-0761, Vorinostat)

    Completed
    Has Results
    • Cutaneous T-Cell Lymphoma
    • Birmingham, Alabama
    • +72 more
    Jul 22, 2022

    Psoriatic Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib)

    Terminated
    Has Results
    • Psoriatic Arthritis
    • Covina, California
    • +58 more
    Feb 18, 2022

    Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Cryoablation
    • Cryoablation combined with PD1 Inhibitor
    • (no location specified)
    Mar 28, 2023

    COVID-19 Trial in Mexico City (Maraviroc + Currently used therapy, Curently used therapy for COVID-19 non-critical patients,

    Terminated
    • COVID-19
    • Maraviroc + Currently used therapy
    • +3 more
    • Mexico City, Cdmx, Mexico
      Hospital General de México "Dr. Eduardo Liceaga"
    May 31, 2022

    Lymphoma Trial in Duarte (biological, drug, procedure)

    Completed
    • Lymphoma
    • lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Nov 13, 2019

    Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in Worldwide (JBH492)

    Recruiting
    • Non-Hodgkins Lymphoma
    • Chronic Lymphocytic Leukemia
    • Phoenix, Arizona
    • +10 more
    Nov 11, 2022

    Chronic Migraine Trial in Worldwide (Atogepant 30 mg, Atogepant 60 mg, Placebo)

    Completed
    • Chronic Migraine
    • Atogepant 30 mg
    • +2 more
    • Phoenix, Arizona
    • +149 more
    Jan 31, 2022

    CAP-100 for Relapsed/Refractory Chronic Lymphocytic Leukemia

    Recruiting
    • Lymphocytic Leukemia, Chronic
    • SLL
    • Durham, North Carolina
    • +1 more
    Sep 16, 2021

    Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency Trial in Paris (ARTEGENE drug product)

    Not yet recruiting
    • Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
    • ARTEGENE drug product
    • Paris, France
      Department of Pediatric Immunology, Hematology and Rheumatology
    Sep 26, 2022

    Urinary T Lymphocytes Predict Renal Flares in Inactive

    Completed
    • Glomerulonephritis Acute
    • Analysis of urine samples with flow cytometry
    • Berlin, Germany
    • +1 more
    Mar 8, 2022